- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07661407
High-Intensity Laser Therapy (HILT) in Patients With Knee Osteoarthritis
Assessment of the Effectiveness of High-Intensity Laser Therapy (HILT) in the Treatment of Knee Osteoarthritis: A Randomized Placebo-Controlled Trial
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Knee osteoarthritis is one of the leading causes of pain and disability among older adults. Although physiotherapy constitutes a cornerstone of conservative management, the clinical effectiveness of High-Intensity Laser Therapy remains uncertain due to methodological heterogeneity of available studies. This prospective randomized placebo-controlled trial will evaluate whether HILT provides additional benefits when combined with standard physiotherapy.
Participants aged 40-75 years with radiographically confirmed mild-to-moderate knee osteoarthritis and pain intensity of at least 4 points on the Visual Analogue Scale will be enrolled. Participants will be randomly assigned in a 1:1 ratio using block randomization. The intervention period will last two weeks. Both groups will receive the same physiotherapy programme consisting of aerobic, strengthening, balance, proprioceptive, stretching, gait and functional exercises. The experimental group will receive active HILT, whereas the control group will receive sham HILT.
Assessments will be performed at baseline, immediately after treatment and 8 weeks after treatment completion.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Paweł Nalborczyk, MSc PT
- Telefonnummer: +48691219338
- E-post: pnalborczyk@ur.edu.pl
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Radiographically confirmed knee osteoarthritis
- Mild-to-moderate disease severity
- Pain ≥4 on VAS for at least 3 months
- Ability to participate in physiotherapy
- Informed consent
Exclusion Criteria:
- Advanced OA requiring surgery
- Previous knee arthroplasty
- Knee instability
- Acute inflammation
- Neurological disorders affecting gait
- Neuropathies or myopathies
- Active inflammatory arthritis
- Recent lower-limb injury (<6 months)
- Intra-articular injections within 3 months
- Cancer, pregnancy, epilepsy
- Electronic implants or pacemaker
- Active local infection
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Conventional Physiotherapy + HILT
|
Participants will receive a standardized outpatient physiotherapy programme delivered five times per week for two consecutive weeks.
Each session will include aerobic exercise on a stationary bicycle, strengthening exercises, balance and proprioceptive training, functional exercises, stretching exercises, postural exercises, and gait training.
The physiotherapy programme will be identical in both study groups.
Participants will receive High-Intensity Laser Therapy using the ASA Laser HIRO 3.0 device (3 kW).
Treatment will be administered three times per week for two consecutive weeks, resulting in six treatment sessions.
Laser irradiation will be delivered in pulsed mode at a frequency of 20 Hz with a total energy dose of 3000 J per session.
The laser will be applied using a dynamic scanning technique over the anterior, medial, and lateral aspects of the affected knee joint and selected periarticular trigger points.
All procedures will be performed according to a standardized treatment protocol.
Andra namn:
|
|
Sham Comparator: Conventional Physiotherapy + Sham HILT
|
Participants will receive a standardized outpatient physiotherapy programme delivered five times per week for two consecutive weeks.
Each session will include aerobic exercise on a stationary bicycle, strengthening exercises, balance and proprioceptive training, functional exercises, stretching exercises, postural exercises, and gait training.
The physiotherapy programme will be identical in both study groups.
o Participants will undergo a sham High-Intensity Laser Therapy procedure using the same ASA Laser HIRO 3.0 device and treatment schedule as the active intervention group.
The handpiece will be positioned and moved over the treatment area in the same manner as during active treatment; however, no therapeutic laser energy will be delivered.
The device will not emit laser radiation, light signals, or audible treatment sounds.
Session frequency, duration, therapist-patient interaction, and treatment environment will be identical to those of the active HILT group.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale Score
Tidsram: Baseline, immediately after the 2-week intervention, and 8 weeks after completion of treatment.
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale assesses knee pain using 9 items.
Scores are transformed to a 0-100 scale, where 0 represents extreme knee pain and 100 represents no knee pain.
Therefore, higher scores indicate a better outcome (less pain).
The primary endpoint is the change in KOOS Pain subscale score from baseline.
|
Baseline, immediately after the 2-week intervention, and 8 weeks after completion of treatment.
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 41/03/2026
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .